Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agents

This publication has 10 references indexed in Scilit:

• Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
  2006
• The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: A comparison of the omeract rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the sharp/van der heijde radiographic score
  Arthritis & Rheumatism, 2005
• Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging
  Arthritis & Rheumatism, 2002
• Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases.
  2001
• A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
  The Lancet, 1999
• Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis
  Arthritis & Rheumatism, 1999
• Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis.
  1997
• EARLY DETECTION OF CARPAL EROSIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS - A PILOT-STUDY OF MAGNETIC-RESONANCE IMAGING
  1988
• Preliminary criteria for clinical remission in rheumatoid arthritis
  Arthritis & Rheumatism, 1981